Přehled o publikaci
2024
Genotype is associated with left ventricular reverse remodelling and early events in recent-onset dilated cardiomyopathy
KUBANEK, Milos, Jana BINOVA, Lenka PIHEROVA, Alice KREBSOVA, Martin KOTRC et. al.Basic information
Original name
Genotype is associated with left ventricular reverse remodelling and early events in recent-onset dilated cardiomyopathy
Authors
KUBANEK, Milos, Jana BINOVA, Lenka PIHEROVA, Alice KREBSOVA, Martin KOTRC, Hana HARTMANNOVA, Katerina HODANOVA, Dita MUSALKOVA, Viktor STRANECKY, Tomas PALECEK, Anna CHALOUPKA, Ilga GROCHOVA, Jan KREJČÍ, Jana PETRKOVA, Vojtech MELENOVSKY, Stanislav KMOCH and Josef KAUTZNER
Edition
ESC Heart Failure, SAN FRANCISCO, Sons Ltd, 2024, 2055-5822
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001288249100001
EID Scopus
2-s2.0-85200972427
Keywords in English
Genetics; Left ventricular reverse remodelling; Prognosis; Recent-onset dilated cardiomyopathy; Whole-exome sequencing
Links
LM2018132, research and development project. LX22NPO5104, research and development project.
Changed: 31/1/2025 00:50, RNDr. Daniel Jakubík
Abstract
V originále
gt;= 10% relative decrease. Median follow-up was 41 months. RODCM was familial in 98 (25%) individuals. Class 4-5 variants of interest (VOIs) were identified in 125 (32%) cases, with 69 (18%) having a single titin-truncating variant (TTNtv) and 56 (14%) having non-titin (non-TTN) VOIs. The presence of class 4-5 non-TTN VOIs, but not of TTNtv, heralded a lower probability of 12-month LVRR and proved to be an independent baseline predictor both of the primary and the secondary outcome. The negative result of genetic testing was a strong protective baseline variable against occurrence of life-threatening ventricular arrhythmias. Detection of class 4-5 VOIs in genes coding nuclear envelope proteins was another independent predictor of both study outcomes at baseline and also of life-threatening ventricular arrhythmias after 12 months. Class 4-5 VOIs of genes coding cytoskeleton were associated with an increased risk of life-threatening ventricular arrhythmias after baseline assessment. A positive family history of dilated cardiomyopathy alone only related to a lower probability of LVRR at 12 months and at the final follow-up. ConclusionsRODCM patients harbouring class 4-5 non-TTN VOIs are at higher risk of progressive heart failure and life-threatening ventricular arrhythmias. Genotyping may improve their early risk stratification at baseline assessment.